Orpea SA
PAR:ORP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orpea SA
PAR:ORP
|
FR |
|
B Riley Financial Inc
NASDAQ:RILY
|
US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Lunai Bioworks Inc
NASDAQ:LNAI
|
US |
|
C
|
Coronation Fund Managers Ltd
JSE:CML
|
ZA |
|
Cosco Shipping International (Singapore) Co Ltd
SGX:F83
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ORP's stock price target?
Not Available
ORP doesn't have any price targets made by Wall Street professionals.
What is Orpea SA's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Orpea SA's revenue is
10%.
The projected
CAGR
for the next 3 years is
7%.
What is Orpea SA's Net Income forecast?
Projected CAGR
-68%
For the last 8 years the
compound annual growth rate for
Orpea SA's net income is
34%.
The projected
CAGR
for the next 3 years is
-68%.